Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Basic Full List View

By pinki@katapult.biz / February 16, 2025

MEC Basic

Speciality

Author / Speaker

Title

Type of Media

Events

Search Everything

«
1
…
41
42
43
44
45
…
62
»

Updates in Genitourinary Cancers

Updates in Genitourinary Cancers

Sumanta K. Pal, MD

Recent Advances in Acute Leukemias

Recent Advances in Acute Leukemias

Brian Jonas, MD

New Therapeutic Directions in Lung Cancer

New Therapeutic Directions in Lung Cancer

Megan Daly, MD

State of the Art in Gastrointestinal Cancers

State of the Art in Gastrointestinal Cancers

Fadwa Ali, MD

State of the Art Management of Sickle Cell Anemia

State of the Art Management of Sickle Cell Anemia

Oyebimpe Adesina, MD

Update from ASCO/AACR/ESMO in T-cell NHL

Update from ASCO/AACR/ESMO in T-cell NHL

Luis E. Fayad, MD

Modern Challenges and new options for B-cell NHL

Modern Challenges and new options for B-cell NHL

Eduardo Sotomayor, MD

Most Relevant News in Multiple Myeloma in 2021

Most Relevant News in Multiple Myeloma in 2021

Sikander Ailawadhi, MD

New Developments in CLL

New Developments in CLL

Javier Pinilla-Ibarz, MD, PhD

Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC

Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC

Luis E. Raez, MD, FACP, FCCP

Novel Mechanisms of Resistance Identified for Diverse TKIs in NSCLC

Novel Mechanisms of Resistance Identified for Diverse TKIs in NSCLC

John Heymach, MD, PhD

Advances in Targeted Therapy in Lung Cancer

Advances in Targeted Therapy in Lung Cancer

Edgardo S. Santos, MD, FACP

New Developments in Therapeutics for Metastatic Breast Cancer

New Developments in Therapeutics for Metastatic Breast Cancer

Mohammad Jahanzeb, MD, FACP, FASCO

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

Ingrid A. Mayer, MD, MSCI

Novel Frontiers in the Use of ctDNA in Oncology

Novel Frontiers in the Use of ctDNA in Oncology

Christian Rolfo, MD, PhD, MBA, Dr.hc

Advances in Head and Neck Cancers Including Thyroid malignancies

Advances in Head and Neck Cancers Including Thyroid malignancies

Tanguy Seiwert, MD

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Alexander B. Olawaiye, MD

Updates in Kidney and Bladder Cancers

Updates in Kidney and Bladder Cancers

Pedro Barata, MD, MSc

Updates in Cholangiocarcinoma and Pancreas Cancer

Updates in Cholangiocarcinoma and Pancreas Cancer

Mike Cusnir, MD

What is New in Colorectal Cancer

What is New in Colorectal Cancer

John Marshall, MD

Updates in Prostate Cancer

Updates in Prostate Cancer

Ulka Vaishampayan, MD

AML: Current Status and Future Directions

AML: Current Status and Future Directions

George Yaghmour, MD

Leveraging Radiogenomics in Cancer Care

Leveraging Radiogenomics in Cancer Care

Terence M. Williams, MD, PhD

Telemedicine in Cancer in the Age of COVID

Telemedicine in Cancer in the Age of COVID

Howard (Jack) West, MD

Updates in Treatment of Lymphoma

Updates in Treatment of Lymphoma

Joseph M. Tuscano, MD

PK and PD Considerations in Early Phase Clinical Trials

PK and PD Considerations in Early Phase Clinical Trials

Timothy Synold, PharmD

Advanced Urothelial Cancer

Advanced Urothelial Cancer

Sarmad Sadeghi, MD PhD

Management of Immune Related Adverse Events

Management of Immune Related Adverse Events

Alicia Rigby, RN, MSN, FNP, AOCNP

Updates in Targeted Therapy for NSCLC

Updates in Targeted Therapy for NSCLC

Jonathan W. Reiss, MD, MS

Castration Resistant Prostate Cancer: What is the optimal approach?

Castration Resistant Prostate Cancer: What is the optimal approach?

David I. Quinn, MBBS, PhD, FRACP, FACP

Displaying 1,261 - 1,290 of 1,833

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Useful Links

Library
Live Events

Categories

MEC Basic
MEC Plus
Purchased

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok